Neurontin

Aaron Kesselheim of Harvard University tracked sales of Neurontin, a drug approved for epilepsy but prescribed for much more. By 2004, when Pfizer paid$ 430m in penalties, annual sales had reached$ 2.7 billion.

凯泽尔海姆对批准为治疗癫痫、实际上用途更广的处方药“镇顽癫”进行了跟踪后发现，到2004年，辉瑞支付的罚款为4.3亿美元，而这种药每年销售已达27亿美元。

This model has already successfully predicted the efficacy of motor neuron protection by riluzole and neurontin, which are being used for human motor neuron disease.

该模型已经成功地预言了力如唑（riluzole）和加巴喷丁（neurontin）有效的运动神经元保护作用，这两种药已经用于人类运动神经元病。

One example is another case involving Pfizer, this one for the off-label marketing of Neurontin.

一个实例是辉瑞的另一起官司，加巴喷丁适应症以外的市场营销。